HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 01, January 2019 – Taiwan medical tourism - Combining medical travel and tourist destination       » New breast cancer drug now available in China       » Chinese scientists make important cancer finding       » Japan's plan to revolutionise healthcare sector with tech       » GSK to buy oncology drugmaker Tesaro for US$5.1 billion       » There is hope for anticancer vaccines      
INSIDE INDUSTRY
Japan’s plan to revolutionise healthcare sector with tech
Emphasis on technology in healthcare will create new dimensions for pharma and medical devices companies and create a new healthcare system which could be an exemplar for other countries

Japan’s plan to effectively use technologies including big data and artificial intelligence (AI) to revolutionise the country’s healthcare system could soon be an exemplar for other countries, says GlobalData, a data and analytics company.

Japan had earmarked healthcare as one of the priority sectors and began overhauling it in 2016 under the ‘Japan Revitalization Strategy 2016 – Towards the Fourth Industrialization’. As part of the strategy, providing diagnosis support and innovative new drugs and medical devices by using big data; providing personalised healthcare services using Internet of Things (IoT); and improving the quality and productivity of nursing care by using technologies such as robots and sensors were identified as the three focus areas.

Prashant Khadayate, pharma analyst at GlobalData commented, “Japan has always been a frontrunner in the usage of technology. There are pressing issues within Japan’s economy such as the economic slowdown, rising healthcare expenditure and the ageing population, which are going to affect the country’s growth in the coming decade or so. Therefore, the focus on technology is the need of the hour. Effective use of technologies including big data can bring revolutionary changes by improving operational efficiency at various stages of healthcare delivery while reducing cost and benefitting patients”.

The Japanese government has initiated various steps to revamp the country’s healthcare system. Recently, they implemented Jisedai Iryo-kiban Ho (the next-generation medical infrastructure law) to allow medical big data to be used anonymously for research related to diseases and development of newer drugs.

Under this law, data privacy has been given utmost importance, be it for collection or sharing. The data sharing aspect is critical as some concerns were raised in the UK where healthcare data of up to 1.6 million patients were shared with Google, including access to sensitive data.

Moreover, Japan has completed its Medical Information Database Network (MID-NET) Project to establish a new medical information database network for use in safety assessment by the Ministry of Health, Labor, and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA). The approach would be based on pharmaco-epidemiological methods using real-world data.

MID-NET database captures medical information including laboratory test results, claim data and prospective payment data for four million acute in-patients. This database is currently operational and will further help in improving the drug development process and reducing the time for approval of both drugs and medical devices in Japan.

In addition, Japan aims to establish 10 AI-based hospitals by 2022 with an investment of more than US$100m. With this step, the government plans to tackle the problem of lack of medical personnel and the rise in medical expenses.

Click here for the complete issue.

NEWS CRUNCH  
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy